Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH PUBLISHING
JIB
BioConferenceLive

Partners to Develop Complex Multilayer Films for Biopharmaceutical Applications

By BiotechDaily International staff writers
Posted on 21 Jun 2011
Two European manufacturers have signed an exclusive cooperation agreement to develop, manufacture, and supply polymer plastic films for the biopharmaceutical market.

Sartorius Stedim Biotech (Aubagne, France) - a leading provider of equipment and services for development, quality assurance, and production processes in the biopharmaceutical industry - and Südpack Medica AG (Ochsenhausen, Germany) - a manufacturer of innovative packaging solutions that belongs to the Südpack Group - have agreed to form a strategic partnership for an initial term of 10 years.

Südpack will produce plastic film materials for Sartorius Stedim Biotech to be employed in the manufacture of single-use bags and systems. These single-use bags are primarily for laboratory applications by customers in the pharmaceutical industry for cell cultivation, transportation, and storage of biopharmaceutical liquids.

In addition, the two companies will collaborate on the development of novel multilayer films with improved product characteristics. The first product innovations from this cooperation are expected in approximately one year from now.

"Südpack Medica AG has already been developing and manufacturing packaging solutions for medical product manufacturers for many years. Cooperation with Sartorius Stedim Biotech is now an important step into the new, promising markets of the future. We are proud that Sartorius Stedim Biotech, one of the market leaders in the biotechnology industry, has selected us as a partner to jointly develop innovative film laminates. This also tells me that we are on the right track with our strategy of continuously investing in new technologies and developments," said Johannes Remmele, managing director of Südpack.

"Through the alliance with Südpack, we have gained an excellent partner for the development and manufacture of complex multi-layer films that we process in the production of our single-use bags. By supplying innovative single-use products, we are striving to continue offering our customers real added value in the future as well. For this reason, the strategic partnership with Südpack represents a key step for us," said Dr. Oscar-Werner Reif, executive vice president of research and development at Sartorius Stedim Biotech.

Related Links:
Sartorius Stedim Biotech
Südpack Medica AG


comments powered by Disqus

Channels

Genomics/Proteomics

view channel
Image: Microcomputed tomography images (top) and histology images (bottom) of the knees of mice fed a very high fat diet containing omega-3 fatty acid supplement (left) or only omega-6 fatty acids (right) after a knee injury. The omega-6 diet showed abnormal bone remodeling and calcified tissue formation in the joint (white arrow). The omega-6 diet also showed significant loss of cartilage (red staining, yellow arrowhead) and increased joint inflammation (Photo courtesy of Duke University).

Dietary Omega-3 Fatty Acids Moderate Severity of Osteoarthritis in a Mouse Model

Researchers working with an osteoarthritis (OA) obese mouse model found that the fat content of the animals' diet contributed more to the development or arrest of OA than did body weight.... Read more

Drug Discovery

view channel
Image: Molecular rendering of the crystal structure of parkin (Photo courtesy of Wikimedia Commons).

Cinnamon Feeding Blocks Development of Parkinson's Disease in Mouse Model

A team of neurological researchers has identified a molecular mechanism by which cinnamon acts to protect neurons from damage caused by Parkinson's disease (PD) in a mouse model of the syndrome.... Read more

Therapeutics

view channel

Vaccine Being Developed for Heart Disease Close to Reality

The world’s first vaccine for heart disease is becoming a possibility with researchers demonstrating significant arterial plaque reduction in concept testing in mice. Klaus Ley, MD, from the La Jolla Institute for Allergy and Immunology (LA Jolla, CA, USA), and a vascular immunology specialist, is leading the vaccine... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.